DK0587121T3 - Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf - Google Patents

Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf

Info

Publication number
DK0587121T3
DK0587121T3 DK93114343T DK93114343T DK0587121T3 DK 0587121 T3 DK0587121 T3 DK 0587121T3 DK 93114343 T DK93114343 T DK 93114343T DK 93114343 T DK93114343 T DK 93114343T DK 0587121 T3 DK0587121 T3 DK 0587121T3
Authority
DK
Denmark
Prior art keywords
cefepime
cephalosporine
dihydrochloride dihydrate
crystalline dihydrochloride
dihydrochloride salt
Prior art date
Application number
DK93114343T
Other languages
Danish (da)
English (en)
Inventor
Munir N Nassar
Gary M F Lim
Elizabeth Ann Garofalo
Murray Arthur Kaplan
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0587121T3 publication Critical patent/DK0587121T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DK93114343T 1992-09-08 1993-09-07 Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf DK0587121T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94159192A 1992-09-08 1992-09-08
US94158492A 1992-09-08 1992-09-08

Publications (1)

Publication Number Publication Date
DK0587121T3 true DK0587121T3 (da) 1999-07-26

Family

ID=27130161

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93114343T DK0587121T3 (da) 1992-09-08 1993-09-07 Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf

Country Status (9)

Country Link
EP (1) EP0587121B1 (es)
JP (1) JP3868008B2 (es)
AT (1) ATE173265T1 (es)
AU (1) AU671658B2 (es)
CA (1) CA2101571A1 (es)
DE (1) DE69322030T2 (es)
DK (1) DK0587121T3 (es)
ES (1) ES2124279T3 (es)
GR (1) GR3029306T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498777A (en) * 1994-07-20 1996-03-12 Merck & Co., Inc. 3-thioheteroaryl cephalosporin compounds, compositions and methods of use
JP2914324B2 (ja) 1995-10-23 1999-06-28 味の素株式会社 ピペリジン誘導体の結晶並びにその製造中間体及び製造方法
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
JP2008524204A (ja) * 2004-12-17 2008-07-10 ヴィーナス・レメディーズ・リミテッド 感染の処置に全面的解決を与えるための抗生物質の組合せ
US7989631B2 (en) * 2006-02-10 2011-08-02 Amgen Inc. Hydrate forms of AMG706
CN102351885B (zh) * 2011-08-19 2012-08-22 深圳立健药业有限公司 用于制备头孢呋辛-l-精氨酸水合物的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457295A1 (fr) * 1979-05-25 1980-12-19 Glaxo Group Ltd Composes intermediaires pour la preparation de cephalosporines
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
EP0175544A3 (en) * 1984-09-17 1987-06-03 Eli Lilly And Company An improved process for cephalosporin intermediates
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
YU81692A (sh) * 1991-09-10 1995-03-27 Bristol-Myers Co. Postupak za proizvodnju cefalosporinskog antibiotika
IL103110A (en) * 1991-09-10 1997-04-15 Bristol Myers Squibb Co Anhydrous process for preparing cefepime dihydrochloride hydrate

Also Published As

Publication number Publication date
ES2124279T3 (es) 1999-02-01
DE69322030T2 (de) 1999-07-15
DE69322030D1 (de) 1998-12-17
AU4616493A (en) 1994-03-17
EP0587121A1 (en) 1994-03-16
CA2101571A1 (en) 1994-03-09
ATE173265T1 (de) 1998-11-15
EP0587121B1 (en) 1998-11-11
AU671658B2 (en) 1996-09-05
JP3868008B2 (ja) 2007-01-17
GR3029306T3 (en) 1999-05-28
JPH06192271A (ja) 1994-07-12

Similar Documents

Publication Publication Date Title
HU9401473D0 (en) Organic salts of n,n`-diacetyl-cystine
DK0471236T3 (da) Imidazopyridinderivater og deres anvendelse
AR005597A1 (es) Derivados de benzoxazina , composiciones farmaceuticas para el tratamiento de infecciones bacterianas, y metodo para la preparacion de dichos derivados.
EP0472060A3 (en) Antibiotic c-7 catechol-subtituted cephalosporin compounds, compositions, and use thereof
IT8947539A0 (it) Sali cefalosporinici e relative composizioni iniettabili, nonche' procedimento di preparazione
DK454086A (da) Quinolinderivater og deres anvendelse
PT992509E (pt) Novos derivados macrolidos
DE69103490D1 (de) Cephalosporinderivate mit in der Lage 3 eine Thioalkylthiogruppe.
DE3585980D1 (de) Hydrazinderivate und ihre verwendung.
DK0587121T3 (da) Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf
IS3951A (is) Cephalosporinafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja
DK0484966T3 (da) 7-Acryl-3-(substitueret carbamoyloxy)cephemforbindelser, anvendelse deraf og fremgangsmåde deraf
FI931703A (fi) Anordning foer uppbaerande av ett flaekthus med hjaelp av en elastisk ring
BR8900940A (pt) Composicao organica estavel
NO923983L (no) Bisfenyletanderivater, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
FI862566A (fi) Foerfarande foer framstaellning av nya penemderivat.
DE69028285D1 (de) Cephalosporinderivate, ihre Herstellung und Anwendungen
ES449688A1 (es) Procedimiento para la preparacion de un acido 7-(alfa-amino-w-(3, 4-metilenodioxifenil) acilamido) cefalosporanico.
ATA294388A (de) Kristallines, schwerloesliches hydrojodisadditionssalz von 7-amino-3-(4-carbamoyl-1chinuclidinium)methyl-3-cephem-4-carboxylat
NO884486L (no) Fremgangsmaate for fremstilling av cefalosporinderivater med forbedrede farmakokinetika.
IL99782A0 (en) Ergoline derivatives,their production and pharmaceutical compositions containing them
ITMI910517A0 (it) Composizione solida stabilizzante
DE3578172D1 (de) 2,5-pyrrolidindion-derivate mit antiarrhythmischer wirkung.
BG97117A (bg) Цефалоспоринови производни
NO890341D0 (no) Produksjon av alkaloider med hoey renhet.